My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Public release date: 12-Sep-2007
(updated 2004 figure’s)
Lipitor – 9 Billion
Zocor – 4.7 Billion
Nexium – 4.2 Billion
Prevacid – 2.4 Billion
Zoloft – 1.9 Billion
Plavix – 1.7 Billion
Norvasc – 1.5 Billion
The survey also excluded drugs that are administered in a doctor’s office or hospital, such as cancer drugs.
The full survey is available at http://www.meps.ahrq.gov/mepsweb/data_files/publications/st180/s tat180.pdf.
I have a strong affinity for the sciences which led me to create my sites. My compulsion for the past decade has been reviewing literally every peer-reviewed research article. Which can easily be validated by following my posts. To me, science is where the real news is, as it will mold our destiny beyond that of politics or economics. ;-)
Subscribe now to keep reading and get access to the full archive.